Virological failure and HIV drug resistance among adults living with HIV on second‐line antiretroviral therapy in the Asia‐Pacific

Objectives To assess second‐line antiretroviral therapy (ART) virological failure and HIV drug resistance‐associated mutations (RAMs), in support of third‐line regimen planning in Asia. Methods Adults > 18 years of age on second‐line ART for ≥ 6 months were eligible. Cross‐sectional data on HIV v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2021-03, Vol.22 (3), p.201-211
Hauptverfasser:	Ross, J, Jiamsakul, A, Kumarasamy, N, Azwa, I, Merati, TP, Do, CD, Lee, MP, Ly, PS, Yunihastuti, E, Nguyen, KV, Ditangco, R, Ng, OT, Choi, JY, Oka, S, Sohn, AH, Law, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Anti-HIV Agents - adverse effects Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Asia CD4 antigen Confidence intervals Cross-Sectional Studies Drug resistance Drug Resistance, Viral Drug therapy Durability Exposure Failure HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Infectious Diseases Life Sciences & Biomedicine Load resistance Male Mutation Non-nucleoside reverse transcriptase inhibitors Nucleoside reverse transcriptase inhibitors Protease inhibitors Proteinase inhibitors Regression analysis Risk analysis Risk factors RNA-directed DNA polymerase Science & Technology second‐line antiretroviral therapy Sexually transmitted diseases Statistical analysis STD Treatment Failure Viral Load virological failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!